Headache hours, days with severe headache intensity (defined as pain ≥7/10 on a numeric analog scale), days with acute headache medication use and days with triptan use showed a trend to increase over time after trial termination but were still numerically lower than baseline at all examined time points (Table 1 ).
← all excerpts
Erenumab and galcanezumab in chronic migraine prevention: effects after treatment termination.
1
—
—